Inhaltsbereich
| 2458 Einträge | 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 › » |
Seite 1 / 123
 Druckansicht
|
| Impact of CYP24A1 overexpression on growth of colorectal tumour xenografts in mice fed with vitamin D and soy. |
| Höbaus J, Tennakoon S, Heffeter P, Groeschel C, Aggarwal A, Hummel DM, Thiem U, Marculescu R, Berger W, Kállay E |
| International journal of cancer. Journal international du cancer. 2015 Aug 3. doi: 10.1002/ijc.29717 |
| PMID: 26238339 |
| Fibroblast growth factor receptor 3 isoforms: novel therapeutic targets for hepatocellular carcinoma? |
| Paur J, Nika L, Maier C, Moscu-Gregor A, Kostka J, Huber D, Mohr T, Heffeter P, Schrottmaier WC, Kappel S, Kandioler D, Holzmann K, Marian B, Berger W, Grusch M, Grasl-Kraupp B |
| Hepatology (Baltimore, Md.). 2015 Aug 1. doi: 10.1002/hep.28023 |
| PMID: 26235436 |
| Myeloid STAT3 promotes formation of colitis-associated colorectal cancer in mice. |
| Pathria P, Gotthardt D, Prchal-Murphy M, Putz EM, Holcmann M, Schlederer M, Grabner B, Crncec I, Svinka J, Musteanu M, Hoffmann T, Filipits M, Berger W, Poli V, Kenner L, Bilban M, Casanova E, Müller M, Strobl B, Bayer E, Mohr T, Sexl V, Eferl R |
| Oncoimmunology. 2015 Jan 22. doi: 10.1080/2162402X.2014.998529. pii: 998529. pmc: PMC4485776 |
| PMID: 26137415 |
| Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma. |
| Laszlo V, Hoda MA, Garay T, Pirker C, Ghanim B, Klikovits T, Dong YW, Rozsas A, Kenessey I, Szirtes I, Grusch M, Jakopovic M, Samarzija M, Brcic L, Kern I, Rozman A, Popper H, Zöchbauer-Müller S, Heller G, Altenberger C, Ziegler B, Klepetko W, Berger W, Dome B, Hegedus B |
| The Journal of pathology. 2015 May 26. doi: 10.1002/path.4567 |
| PMID: 26011651 |
| EVI1 promotes tumor growth via transcriptional repression of MS4A3. |
| Heller G, Rommer A, Steinleitner K, Etzler J, Hackl H, Heffeter P, Tomasich E, Filipits M, Steinmetz B, Topakian T, Klingenbrunner S, Ziegler B, Spittler A, Zöchbauer-Müller S, Berger W, Wieser R |
| Journal of hematology & oncology. 2015 Mar 21. doi: 10.1186/s13045-015-0124-6. pii: 10.1186/s13045-015-0124-6. pmc: PMC4389965 |
| PMID: 25886616 |
| Sphaeropsidin A shows promising activity against drug-resistant cancer cells by targeting regulatory volume increase. |
| Mathieu V, Chantôme A, Lefranc F, Cimmino A, Miklos W, Paulitschke V, Mohr T, Maddau L, Kornienko A, Berger W, Vandier C, Evidente A, Delpire E, Kiss R |
| Cellular and molecular life sciences : CMLS. 2015 Apr 14. doi: 10.1007/s00018-015-1902-6. pii: 10.1007/s00018-015-1902-6 |
| PMID: 25868554 |
| Structure-Related Mode-of-Action Differences of Anticancer Organoruthenium Complexes with β-Diketonates. |
| Seršen S, Kljun J, Kryeziu K, Panchuk R, Alte B, Körner W, Heffeter P, Berger W, Turel I |
| Journal of medicinal chemistry. 2015 Apr 17. doi: 10.1021/acs.jmedchem.5b00288 |
| PMID: 25856666 |
| Effect of 1,25-dihydroxyvitamin D3 on the Wnt pathway in non-malignant colonic cells. |
| Gröschel C, Aggarwal A, Tennakoon S, Höbaus J, Prinz-Wohlgenannt M, Marian B, Heffeter P, Berger W, Kállay E |
| The Journal of steroid biochemistry and molecular biology. 2015 Mar 14. pii: S0960-0760(15)00049-7. doi: 10.1016/j.jsbmb.2015.02.011 |
| PMID: 25777538 |
| Active vitamin D potentiates the anti-neoplastic effects of calcium in the colon: A cross talk through the calcium-sensing receptor. |
| Aggarwal A, Höbaus J, Tennakoon S, Prinz-Wohlgenannt M, Graça J, Price SA, Heffeter P, Berger W, Baumgartner-Parzer S, Kállay E |
| The Journal of steroid biochemistry and molecular biology. 2015 Mar 7. pii: S0960-0760(15)00044-8. doi: 10.1016/j.jsbmb.2015.02.006 |
| PMID: 25758239 |
| Triapine-mediated ABCB1 induction via PKC induces widespread therapy unresponsiveness but is not underlying acquired triapine resistance. |
| Miklos W, Pelivan K, Kowol CR, Pirker C, Dornetshuber-Fleiss R, Spitzwieser M, Englinger B, van Schoonhoven S, Cichna-Markl M, Koellensperger G, Keppler BK, Berger W, Heffeter P |
| Cancer letters. 2015 Mar 5. pii: S0304-3835(15)00164-0. doi: 10.1016/j.canlet.2015.02.049 |
| PMID: 25749419 |
| Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis. |
| Spiegl-Kreinecker S, Lötsch D, Ghanim B, Pirker C, Mohr T, Laaber M, Weis S, Olschowski A, Webersinke G, Pichler J, Berger W |
| Neuro-oncology. 2015 Feb 13. pii: nov010. doi: 10.1093/neuonc/nov010 |
| PMID: 25681309 |
| Distinct Epidemiology and Clinical Consequence of Classic Versus Rare EGFR Mutations in Lung Adenocarcinoma. |
| Lohinai Z, Hoda MA, Fabian K, Ostoros G, Raso E, Barbai T, Timar J, Kovalszky I, Cserepes M, Rozsas A, Laszlo V, Grusch M, Berger W, Klepetko W, Moldvay J, Dome B, Hegedus B |
| Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2015 Apr 22. doi: 10.1097/JTO.0000000000000492 |
| PMID: 25664625 |
| Prenylation inhibition-induced cell death in melanoma: reduced sensitivity in BRAF mutant/PTEN wild-type melanoma cells. |
| Garay T, Kenessey I, Molnár E, Juhász É, Réti A, László V, Rózsás A, Dobos J, Döme B, Berger W, Klepetko W, Tóvári J, Tímár J, Hegedűs B |
| PloS one. 2015 Feb 3. doi: 10.1371/journal.pone.0117021. pii: PONE-D-14-03469. pmc: PMC4315579 |
| PMID: 25646931 |
| Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study. |
| Ghanim B, Klikovits T, Hoda MA, Lang G, Szirtes I, Setinek U, Rozsas A, Renyi-Vamos F, Laszlo V, Grusch M, Filipits M, Scheed A, Jakopovic M, Samarzija M, Brcic L, Stancic-Rokotov D, Kern I, Rozman A, Dekan G, Klepetko W, Berger W, Glasz T, Dome B, Hegedus B |
| British journal of cancer. 2015 Jan 29. pii: bjc20159. doi: 10.1038/bjc.2015.9. pmc: PMC4453963 |
| PMID: 25633038 |
| Vemurafenib resistance signature by proteome analysis offers new strategies and rational therapeutic concepts. |
| Paulitschke V, Berger W, Paulitschke P, Hofstätter E, Knapp B, Dingelmaier-Hovorka R, Födinger D, Jäger W, Szekeres T, Meshcheryakova A, Bileck A, Pirker C, Pehamberger H, Gerner C, Kunstfeld R |
| Molecular cancer therapeutics. 2015 Jan 22. pii: 1535-7163.MCT-14-0701. doi: 10.1158/1535-7163.MCT-14-0701 |
| PMID: 25612618 |
| The naturally born fusariotoxin enniatin B and sorafenib exert synergistic activity against cervical cancer in vitro and in vivo. |
| Dornetshuber-Fleiss R, Heilos D, Mohr T, Richter L, Süssmuth RD, Zlesak M, Novicky A, Heffeter P, Lemmens-Gruber R, Berger W |
| Biochemical pharmacology. 2014 Dec 31. pii: S0006-2952(14)00727-8. doi: 10.1016/j.bcp.2014.12.013. pmc: PMC4379350. mid: EMS62789 |
| PMID: 25557295 |
| Calpain-mediated integrin deregulation as a novel mode of action for the anticancer gallium compound KP46. |
| Jungwirth U, Gojo J, Tuder T, Walko G, Holcmann M, Schöfl T, Nowikovsky K, Wilfinger N, Schoonhoven S, Kowol CR, Lemmens-Gruber R, Heffeter P, Keppler BK, Berger W |
| Molecular cancer therapeutics. 2014 Jul 31. pii: 1535-7163.MCT-14-0087. doi: 10.1158/1535-7163.MCT-14-0087 |
| PMID: 25082959 |
| Fibroblast growth factor receptor 4: a putative key driver for the aggressive phenotype of hepatocellular carcinoma. |
| Gauglhofer C, Paur J, Schrottmaier WC, Wingelhofer B, Huber D, Naegelen I, Pirker C, Mohr T, Heinzle C, Holzmann K, Marian B, Schulte-Hermann R, Berger W, Krupitza G, Grusch M, Grasl-Kraupp B |
| Carcinogenesis. 2014 Jul 16. pii: bgu151. doi: 10.1093/carcin/bgu151 |
| PMID: 25031272 |
| Spatio-temporally precise activation of engineered receptor tyrosine kinases by light. |
| Grusch M, Schelch K, Riedler R, Reichhart E, Differ C, Berger W, Inglés-Prieto Á, Janovjak H |
| The EMBO journal. 2014 Jul 1. pii: embj.201387695. doi: 10.15252/embj.201387695. pmc: PMC4194103 |
| PMID: 24986882 |
| Apelin promotes lymphangiogenesis and lymph node metastasis. |
| Berta J, Hoda MA, Laszlo V, Rozsas A, Garay T, Torok S, Grusch M, Berger W, Paku S, Renyi-Vamos F, Masri B, Tovari J, Groger M, Klepetko W, Hegedus B, Dome B |
| Oncotarget. 2014 Jul 21. pii: 2032. pmc: PMC4147335 |
| PMID: 24962866 |
| 2458 Einträge | 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 › » |
Seite 1 / 123
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
